New Delhi, 11 Jan 2025: The Central Drugs Standard Control Organisation’s (CDSCO’s) draft rules for re-classification of medical devices based on their risk profile has received wide support from the industry, as it will allow centralaised, faster approval of high-ris......
View Details

Related News

• Nepal drug regulator tells pharmacies to stop selling illegal food supplements and cosmetics (11-01-2025)

---

• Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules (11-01-2025)

---

• Medtech industry expects regulatory body to reclassify more medical devices (11-01-2025)

---

• IDMA plans extensive workshops on revised Schedule M to assist pharma MSMEs (11-01-2025)

---

• Action against quack: 44 types of medicines seized, accused absconding (11-01-2025)

---

• Customs arrests exporter for smuggling tramadol to Africa (10-01-2025)

---

• Karnataka HM Dinesh Gundu Rao seeks reforms in drug regulatory framework (10-01-2025)

---

• Bacteria Use Natural Products to Expose Competitors to Viruses (10-01-2025)

---

• Centre to reclassify medical devices to bring regulatory uniformity (10-01-2025)

---

• TechInvention partners with Ethiopia’s Ministry of Health to advance vaccine manufacturing in Africa (10-01-2025)

---